Fig. 1 · Structure

Documents & Downloads

Orientin

Cat. No. A12096 CAS 28608-75-5
Orientin is a flavone, a chemical flavonoid-like compound. It is the 8-C glucoside of luteolin

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Orientin Research Summary

This section summarizes 1 in vitro study and 2 in vivo studies of Orientin from 2 published references.

Orientin In Vitro Studies

Orientin was evaluated for effects on cell viability in chondrocytes isolated from Wistar rat knees. Following treatment for 24 hours, no significant cytotoxic effect was observed except at 100 μM. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Cytotoxicity assessment in rat chondrocytes

Cell-based study · chondrocytes were digested from the knees of three-week-old Wistar rats [1]

Chondrocytes isolated from Wistar rat knees were treated with Orientin for 24 hours and assessed for cell viability. Orientin produced no significant cytotoxic effect except at 100 μM.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell viabilityReported result orientin produced no significant cytotoxic effect except at 100 μM[1]

Literature-Reported Treatment Conditions

Treatment concentration
0, 5, 10, 20, and 100 μM
Exposure duration
for 24 hours
Method
Chondrocytes were treated
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Orientin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Methods > Extraction and culture of chondrocytes (S10); Methods > Cell viability assay (S15); Results > Cytotoxic effects of orientin on chondrocyte viability (S71, S72); Fig. 1 legend (S133)

cell viability: cell viability; comparator: 0 μM — Methods > Cell viability assay (S15); Results > Cytotoxic effects of orientin on chondrocyte viability (S72)

Orientin In Vivo Studies

Orientin was classified as non-toxic in an Artemia lethality assay measuring mortality. In Wistar rats with OA following ACL transection, intragastric Orientin at 40 mg/kg increased articular space width to 248.9% of the OA group. [2,1]

Orientin in an Artemia Lethality Assay

Animal study · Artemia lethality assay [2]

Orientin exposure was classified as non-toxic in an Artemia lethality assay measuring mortality.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
mean % mortalityLC50 >2,000 µg/mL[2]
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Orientin 62.5–2,000 µg/mL400 µL of artificial seawater (Red Sea Pharm Ltd, Pituach, Israel) as a negative controlLC50 value >2,000 µg/mL; Non-toxic[2]
Orientin 62.5–2,000 µg/mL
Model: Artemia lethality assay
Reported limits: Not stated in the sentences used: route, schedule, vehicle.
Methods and source locations

Compound reported in the paper: Orientin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

RESULTS > Toxicity evaluation (S38); MATERIALS AND METHODS > Toxicity studies (S93, S94); TABLE 3 legend (S135); TABLE 3 (T3.h2, T3.r11)

mean % mortality: mean % mortality; comparator: 400 µL of artificial seawater (Red Sea Pharm Ltd, Pituach, Israel) as a negative control — RESULTS > Toxicity evaluation (S38); TABLE 3 (T3.h2, T3.r11)

Orientin 62.5–2,000 µg/mL · MATERIALS AND METHODS > Toxicity studies (S93); TABLE 3 (T3.h2, T3.r11)

Orientin and Articular Space Width in Rats

Animal study · eight-week-old male Wistar rats; OA model; n = 5 [1]

In Wistar rats with OA following ACL transection, intragastric Orientin at 40 mg/kg increased articular space width to 248.9% of the OA group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
articular space widtharticular space width 248.9% of the OA group[1]

Conditions shared by the study groups

Route
intragastrically
Treatment course
After the surgery; daily for eight weeks
Vehicle
dissolved in dimethyl sulfoxide (DMSO) and further diluted in saline
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Orientin 40 mg/kgOA group; equivalent DMSO and salineorientin could notably increase the width to 248.9% of the OA group[1]
Orientin 40 mg/kg
Model: eight-week-old male Wistar rats; OA model; n = 5
Methods and source locations

Compound reported in the paper: Orientin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Methods > Rat model of OA (S49, S51, S52); Results > Orientin alleviates OA process in an ACLT rat model (S127); Fig. 9 legend (S158)

articular space width: articular space width; comparator: OA group; equivalent DMSO and saline — Results > Orientin alleviates OA process in an ACLT rat model (S127)

Orientin 40 mg/kg · Methods > Rat model of OA (S52); Results > Orientin alleviates OA process in an ACLT rat model (S127)

Specifications

Manufacturer Adooq Bioscience
CAS Number 28608-75-5
Formula C21H20O11
Molecular Weight 448.38
SMILES
C1=CC(=C(C=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 83 mg/mL (185.11 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Orientin Research References

  1. [1] Chen H, Liu S, Xing J, et al. Orientin alleviates chondrocyte senescence and osteoarthritis by inhibiting PI3K/AKT pathway. Bone Joint Res (2025). PMID: 40085067 DOI: 10.1302/2046-3758.143.BJR-2023-0383.R2 Source material
  2. [2] Jawad Yousaf Zai M, Cheesman MJ, Cock IE. Flavonoids identified in Australian Terminalia inhibit methicillin and β-lactam-resistant pathogens, exhibit efflux pump inhibitory activity, and potentiate conventional antibiotics. Microbiol Spectr (2026). PMID: 41543238 DOI: 10.1128/spectrum.02374-25 Source material

Added to your cart

View Cart Checkout
Loading...